Mark Viney

PuriCore

PuriCore (AIM:PURI) is an emerging biopharmaceutical company passionately committed to leveraging its proprietary technologies to protect and improve the health of adults and children. In 2016, the Company began development of small molecule, immunomodulatory drug therapies in inflammatory diseases, with potential application in dermatology, ophthalmology and rare diseases. The Company is listed on the London Stock Exchange and is headquartered in Malvern, Pennsylvania. PuriCore utilizes different formulations to support commercial applications in Supermarket Retail (www.steriloxfresh.com) and Health Sciences. In Supermarket Retail, our products are used by leading supermarket retailers across the United States and Canada to enhance freshness of fruit, vegetable and flower displays. In Health Sciences, we offer a wound care solution, for cleansing, debriding and moisturizing chronic and acute wounds, including diabetic ulcers and burns. Visit us at www.puricore.com